Resurrect Bio raised €6.9M in a Series A round in Feb 2026. The company is based in London, UK. Investors in the round: AgFunder, Calculus Capital, Corteva and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
